## Gene Summary
DYNC2H1 (Dynein Cytoplasmic 2 Heavy Chain 1) is a gene that encodes a protein component of the cytoplasmic dynein 2 complex, which is involved in retrograde intraflagellar transport. This transport is critical for the assembly and maintenance of cilia, cellular structures that play key roles in cell mobility, signaling, and sensory functions. The DYNC2H1 protein functions primarily as a motor for the movement of vesicles and organelles along microtubules. This gene has been shown to be ubiquitously expressed in various human tissues, but it is particularly essential in tissues where cilia are key components, such as in the respiratory tract, kidney, and retinal cells.

## Gene Drugs, Diseases, Phenotypes, and Pathways
Mutations in DYNC2H1 are associated with a spectrum of ciliopathies, which are disorders arising from defective cilia formation or function. This includes skeletal dysplasias like Jeune asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III. These conditions manifest with a range of symptoms including growth retardation, respiratory complications, and limb malformations. The impact of DYNC2H1 on ciliopathy phenotypes emphasizes its critical role in the developmental and functional integrity of cilia. The gene is also involved in key signaling pathways such as hedgehog signaling, which is crucial for embryonic development.

## Pharmacogenetics
DYNC2H1 has not been prominently linked to pharmacogenetic associations with specific drugs. However, given its crucial role in developmental pathways and cellular transport mechanisms, understanding its genetic variations can be relevant in the context of drug treatments for ciliopathies and related disorders. Research into the modulation of cilia function might open up therapeutic avenues that could involve the pharmacological targeting of the dynein motors or associated pathways. Nonetheless, the current pharmacogenetic insights on DYNC2H1 are primarily related to its impact on disease pathophysiology rather than direct drug interactions or responses.